
[Federal Register: May 19, 2009 (Volume 74, Number 95)]
[Notices]               
[Page 23426]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr19my09-70]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2009-N-0664]

 
Gastrointestinal Drugs Advisory Committee; Cancellation

AGENCY:  Food and Drug Administration, HHS.

ACTION:  Notice.

-----------------------------------------------------------------------

SUMMARY:  The meeting of the Gastrointestinal Drugs Advisory Committee 
scheduled for May 20, 2009, is cancelled. This meeting was announced in 
the Federal Register of April 7, 2009 (74 FR 15739). The FDA's Center 
for Drug Evaluation and Research is continuing to review the 
application that was going to be discussed by the committee.

FOR FURTHER INFORMATION CONTACT:  Kristine T. Khuc, Center for Drug 
Evaluation and Research (HFD-21), Food and Drug Administration, 5630 
Fishers Lane (for express delivery, 5630 Fishers Lane, rm. 1093), 
Rockville, MD 20857, 301-827-7001, FAX: 301-827-6776, e-mail: 
Kristine.Khuc@fda.hhs.gov, or FDA Advisory Committee Information Line, 
1-800-741-8138 (301-443-0572 in the Washington, DC area), code 
3014512538. Please call the Information Line for up-to-date information 
on this meeting.

    Dated: May 14, 2009.
Randall W. Lutter,
Deputy Commissioner for Policy.
[FR Doc. E9-11725 Filed 5-15-09; 4:15 pm]

BILLING CODE 4160-01-S
